Stericycle, Inc.
SRCL · NASDAQ
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $648 | $662 | $665 | $652 |
| % Growth | -2% | -0.5% | 2% | – |
| Cost of Goods Sold | $404 | $431 | $438 | $423 |
| Gross Profit | $244 | $230 | $227 | $229 |
| % Margin | 37.6% | 34.8% | 34.2% | 35.1% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $225 | $185 | $170 | $177 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $11 | -$0 | $0 | $0 |
| Operating Expenses | $235 | $185 | $170 | $177 |
| Operating Income | $9 | $46 | $57 | $52 |
| % Margin | 1.4% | 6.9% | 8.6% | 8% |
| Other Income/Exp. Net | -$20 | -$21 | -$18 | -$17 |
| Pre-Tax Income | -$11 | $10 | $21 | $20 |
| Tax Expense | $2 | $4 | $7 | $6 |
| Net Income | -$14 | $6 | $13 | $15 |
| % Margin | -2.1% | 0.9% | 2% | 2.3% |
| EPS | -0.15 | 0.065 | 0.14 | 0.16 |
| % Growth | -331.8% | -53.8% | -12.5% | – |
| EPS Diluted | -0.15 | 0.065 | 0.14 | 0.16 |
| Weighted Avg Shares Out | 93 | 93 | 93 | 93 |
| Weighted Avg Shares Out Dil | 93 | 93 | 93 | 93 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $20 | $21 | $18 | $17 |
| Depreciation & Amortization | $53 | $53 | $54 | $54 |
| EBITDA | $62 | $103 | $111 | $91 |
| % Margin | 9.6% | 15.5% | 16.6% | 14% |